Scott Neilson has been appointed to the position of chief operating officer of AAIPharma. Mr. Neilson will be responsible for the company's global drug development services operations, reporting to chief executive officer and president Dr. Ludo Reynders.
 
Mr. Neilson is an accomplished leader with over 25 years multi-functional experience in all phases of drug development on a global basis. During the past 10 years he has led the turnaround of two of the top six Global Central Laboratories, dramatically improving market share, revenues and profitability, according to an AAIPharma statement. He has also held senior operations positions in clinical research and has a broad spectrum of functional experience including finance, regulatory affairs, human Resources and business development. His experience spans pharmaceuticals and CROs, having worked at MDS Pharma Services, LabCorp, Covance and SmithKline Beecham (now GlaxoSmithKline).
 
“As a company, we have made significant progress across the major lines of business over the last three years,” said Dr. Reynders. “Scott’s appointment underscores our commitment to continuing this progress and our goal of a global leadership position in the markets we serve."